Novartis acknowledges seven previously unknown tumor cases in children treated with Zolgensma

Ameanzisha 1d ago · 1 chapisho · 2 mionekano

Asante

Shiriki

Nukuu

MLA

Micwyn. "Novartis acknowledges seven previously unknown tumor cases in children treated with Zolgensma." Micwyn, 6 Nov. 2026, micwyn.com/t/1555/novartis-acknowledges-seven-previously-unknown-tumor-cases-in-children-treated-w. Accessed 7 Nov. 2026.

APA

Micwyn. (2026, November 6). Novartis acknowledges seven previously unknown tumor cases in children treated with Zolgensma [Online forum post]. Micwyn. https://micwyn.com/t/1555/novartis-acknowledges-seven-previously-unknown-tumor-cases-in-children-treated-w

Chicago

Micwyn. "Novartis acknowledges seven previously unknown tumor cases in children treated with Zolgensma." Micwyn, November 6, 2026. https://micwyn.com/t/1555/novartis-acknowledges-seven-previously-unknown-tumor-cases-in-children-treated-w.

BibTeX

@misc{micwyn_novartis_acknowledges_seven_previ_2026,
  author = {{Micwyn}},
  title = {Novartis acknowledges seven previously unknown tumor cases in children treated with Zolgensma},
  howpublished = {Micwyn},
  year = {2026},
  month = nov,
  url = {https://micwyn.com/t/1555/novartis-acknowledges-seven-previously-unknown-tumor-cases-in-children-treated-w},
  urldate = {2026-11-07}
}

Novartis has acknowledged seven previously unknown instances in which tumors were found in children treated with its spinal muscular atrophy gene therapy, Zolgensma. STAT

STATNovartis cites cases of previously unknown tumors possibly tied to its SMA gene therapyNovartis has acknowledged seven previously unknown instances in which tumors were found in children who were treated with its spinal muscular atrophy therapy, Zolgensma.

How should long-term safety signals from gene therapies be reported as they emerge?

Novartis acknowledges seven previously unknown tumor cases in children treated with Zolgensma

Ongeza sauti yako